- Tytuł:
- The ACT-ONE trial, a multicentre, randomised, double-blind, placebo-controlled, dose-finding study of the anabolic/catabolic transforming agent, MT-102 in subjects with cachexia related to stage III and IV non-small cell lung cancer and colorectal cancer: study design
- Autorzy:
- Źródło:
- Journal of Cachexia, Sarcopenia and Muscle. December 2011 2(4):201-207
Czasopismo naukowe